Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical Completes Patient Recruitment

March 30 (Reuters) - Corline Biomedical AB  CLBIO.ST :
    * CORLINE BIOMEDICAL AB HAS COMPLETED THE PATIENT
RECRUITMENT IN
THE PHASE 1 STUDY
    * CORLINE BIOMEDICAL AB  HAS COMPLETED PATIENT RECRUITMENT
IN THE
ONGOING STUDY RENAPAIR-01, IN WHICH CO'S DRUG CANDIDATE
RENAPARIN® IS EVALUATED FOR SAFETY IN ADMINISTRATION IN
CONNECTION WITH KIDNEY TRANSPLANTATION
    * AS A RESULT OF ONGOING COVID-19 PANDEMIC, CO HAS DECIDED
TO
COMPLETE RECRUITMENT IN RENAPAIR-01 WITH AROUND 90% OF INITIALLY
PLANNED PATIENT POPULATION

Source text for Eikon:  ID:nGNE1Bgghj 
Further company coverage:  CLBIO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Corline Biomedical AB

See all news